Today: 17 April 2026
Strategy (MSTR) stock jumps 9% on bitcoin rebound as traders brace for Tuesday reopen
14 February 2026
1 min read

Strategy (MSTR) stock jumps 9% on bitcoin rebound as traders brace for Tuesday reopen

New York, Feb 14, 2026, 10:32 EST — Market closed

Shares of Strategy Inc (MSTR) surged 8.85% Friday, finishing at $133.88 after bouncing around in a range from $125.76 to $135.25. Volume was hefty, with roughly 24.6 million shares traded.

This shift carries weight—Strategy now acts as a proxy for bitcoin on U.S. equities screens, and there’s a pause ahead: markets shut for Presidents Day on Monday. Next trade? Tuesday.

Bitcoin surged close to 5% late Friday, after January U.S. inflation numbers landed just below forecasts, Reuters reported. That’s giving traders some optimism about possible rate cuts ahead. “A bit of good news as we head into the long holiday weekend,” said Tim Holland, chief investment officer at Orion. Reuters

Bitcoin traded near $69,877 on Saturday, showing a 1.4% gain from the previous close, market data showed.

Strategy, which rebranded from MicroStrategy to Strategy Inc last year, has positioned itself as both a bitcoin-heavy treasury play and a provider of enterprise analytics software. Shares typically amplify bitcoin’s moves, up or down.

The company put out a free writing prospectus on Friday for its “STRC” preferred stock, laying out an 11.25% annualized dividend for February and a monthly cash distribution. According to the SEC filing, the preferred is meant to hover close to $100 per share, with monthly tweaks to the dividend rate to keep it there. Investors on record as of Feb. 15 are set to receive their payout on Feb. 28. Contentstack

Shares tied to crypto tracked the token’s rally Friday. Coinbase jumped 16%, Robinhood notched a 6.8% increase, and Strategy was up roughly 8.9%, according to Barron’s.

The mood remains weak. Bitcoin’s price has dropped almost 50% since its October 6 high, and U.S. spot bitcoin ETFs have bled outflows—$7 billion in November, $2 billion in December, over $3 billion in January, according to Reuters. Coinbase summed it up in its shareholder letter: “Crypto is cyclical, and experience tells us it’s never as good, or as bad as it seems.” Strategy’s equity beta, for better or worse, moves with it. Reuters

Tuesday morning brings U.S. January retail sales and the Empire State manufacturing survey, numbers that have the potential to move rate expectations and show up in bitcoin’s price action.

Strategy’s next signal comes down to two things: does bitcoin stay put around these prices during the slow holiday period, and will any new disclosures—financing details or bitcoin purchases—land ahead of the Feb. 17 open?

Stock Market Today

  • 4 TSX Stocks That Can Withstand a Slowing Economy
    April 16, 2026, 10:19 PM EDT. Investors eyeing the TSX for resilience amid a slowing economy should consider companies with steady cash flow and essential services. Restaurant Brands International (QSR) posted a 5.8% rise in system-wide sales and plans a $1.6 billion shareholder return in 2026. TELUS (T), with a 9% yield, added 377,000 customers in Q4 2025 and targets $2.45 billion free cash flow for 2026. Grocery and pharmacy leader Metro (MRU) saw a 3.3% sales increase despite operational hiccups, trading at 21 times earnings. The list also includes Brookfield Infrastructure Partners (BIP.UN), known for stable assets. These picks blend growth and income, offering stability if economic growth cools but avoids recession.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Broadcom stock price dips toward $325 as analyst warns hyperscalers could squeeze AVGO’s AI chips
Previous Story

Broadcom stock price dips toward $325 as analyst warns hyperscalers could squeeze AVGO’s AI chips

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Next Story

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Go toTop